The bi-directional relationship between parent-child conflict and treatment outcome in treatment-resistant adolescent depression

Manivel Rengasamy, Brandon M. Mansoor, Robert Hilton, Giovanna Porta, Jiayan He, Graham J. Emslie, Taryn Mayes, Gregory N. Clarke, Karen Wagner, Martin B. Keller, Neal D. Ryan, Boris Birmaher, Wael Shamseddeen, Joan Rosenbaum Asarnow, David A. Brent

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objective: To examine the bidirectional relationship between parent-child discord and treatment outcome for adolescent treatment-resistant depression. Method: Depressed youth who had not responded to an adequate course of a selective serotonin reuptake inhibitor (SSRI) were randomized to either a switch to another SSRI or venlafaxine, with or without the addition of cognitive behavior therapy (CBT) in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) study. The Conflict Behavior Questionnaire was used to assess adolescent (CBQ-A) and parent-reported (CBQ-P) parent-child discord. The impact of remission on parent-child conflict, and the differential impact of medication and CBT on the CBQ-A and CBQ-P, were assessed using generalized linear models. Results: Although there were no differential treatment effects on parent or adolescent-report of conflict, remission was associated with improvement in the CBQ-P. In general, intake family conflict did not predict remission, except in the sub-group of participants whose parents reported clinically significant parent-child conflict at intake, for whom high levels of parent-reported conflict predicted a lower likelihood of remission. Conflict also did not moderate treatment response. Conclusions: Remission of depression may be sufficient to reduce parent-reported parent-child conflict. However, higher parent-reported conflict, in the clinically significant range, predicts a lower likelihood of remission from depression. Clinical trial registration information- Treatment of SSRI-Resistant Depression in Adolescents (TORDIA); http://clinicaltrials.gov/; NCT00018902.

Original languageEnglish (US)
Pages (from-to)370-377
Number of pages8
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Volume52
Issue number4
DOIs
StatePublished - Apr 2013
Externally publishedYes

Fingerprint

Treatment-Resistant Depressive Disorder
Parent-Child Relations
Serotonin Uptake Inhibitors
Depression
Cognitive Therapy
Family Conflict
Conflict (Psychology)
Therapeutics
Linear Models
Parents
Clinical Trials

Keywords

  • Cognitive behavior therapy (CBT)
  • Depression
  • Parent-child conflict
  • Selective serotonin reuptake inhibitor (SSRI)
  • Venlafaxine

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Developmental and Educational Psychology

Cite this

The bi-directional relationship between parent-child conflict and treatment outcome in treatment-resistant adolescent depression. / Rengasamy, Manivel; Mansoor, Brandon M.; Hilton, Robert; Porta, Giovanna; He, Jiayan; Emslie, Graham J.; Mayes, Taryn; Clarke, Gregory N.; Wagner, Karen; Keller, Martin B.; Ryan, Neal D.; Birmaher, Boris; Shamseddeen, Wael; Asarnow, Joan Rosenbaum; Brent, David A.

In: Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 52, No. 4, 04.2013, p. 370-377.

Research output: Contribution to journalArticle

Rengasamy, M, Mansoor, BM, Hilton, R, Porta, G, He, J, Emslie, GJ, Mayes, T, Clarke, GN, Wagner, K, Keller, MB, Ryan, ND, Birmaher, B, Shamseddeen, W, Asarnow, JR & Brent, DA 2013, 'The bi-directional relationship between parent-child conflict and treatment outcome in treatment-resistant adolescent depression', Journal of the American Academy of Child and Adolescent Psychiatry, vol. 52, no. 4, pp. 370-377. https://doi.org/10.1016/j.jaac.2013.01.012
Rengasamy, Manivel ; Mansoor, Brandon M. ; Hilton, Robert ; Porta, Giovanna ; He, Jiayan ; Emslie, Graham J. ; Mayes, Taryn ; Clarke, Gregory N. ; Wagner, Karen ; Keller, Martin B. ; Ryan, Neal D. ; Birmaher, Boris ; Shamseddeen, Wael ; Asarnow, Joan Rosenbaum ; Brent, David A. / The bi-directional relationship between parent-child conflict and treatment outcome in treatment-resistant adolescent depression. In: Journal of the American Academy of Child and Adolescent Psychiatry. 2013 ; Vol. 52, No. 4. pp. 370-377.
@article{e998ef9cb43e4a3eb4defd92920707d6,
title = "The bi-directional relationship between parent-child conflict and treatment outcome in treatment-resistant adolescent depression",
abstract = "Objective: To examine the bidirectional relationship between parent-child discord and treatment outcome for adolescent treatment-resistant depression. Method: Depressed youth who had not responded to an adequate course of a selective serotonin reuptake inhibitor (SSRI) were randomized to either a switch to another SSRI or venlafaxine, with or without the addition of cognitive behavior therapy (CBT) in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) study. The Conflict Behavior Questionnaire was used to assess adolescent (CBQ-A) and parent-reported (CBQ-P) parent-child discord. The impact of remission on parent-child conflict, and the differential impact of medication and CBT on the CBQ-A and CBQ-P, were assessed using generalized linear models. Results: Although there were no differential treatment effects on parent or adolescent-report of conflict, remission was associated with improvement in the CBQ-P. In general, intake family conflict did not predict remission, except in the sub-group of participants whose parents reported clinically significant parent-child conflict at intake, for whom high levels of parent-reported conflict predicted a lower likelihood of remission. Conflict also did not moderate treatment response. Conclusions: Remission of depression may be sufficient to reduce parent-reported parent-child conflict. However, higher parent-reported conflict, in the clinically significant range, predicts a lower likelihood of remission from depression. Clinical trial registration information- Treatment of SSRI-Resistant Depression in Adolescents (TORDIA); http://clinicaltrials.gov/; NCT00018902.",
keywords = "Cognitive behavior therapy (CBT), Depression, Parent-child conflict, Selective serotonin reuptake inhibitor (SSRI), Venlafaxine",
author = "Manivel Rengasamy and Mansoor, {Brandon M.} and Robert Hilton and Giovanna Porta and Jiayan He and Emslie, {Graham J.} and Taryn Mayes and Clarke, {Gregory N.} and Karen Wagner and Keller, {Martin B.} and Ryan, {Neal D.} and Boris Birmaher and Wael Shamseddeen and Asarnow, {Joan Rosenbaum} and Brent, {David A.}",
year = "2013",
month = "4",
doi = "10.1016/j.jaac.2013.01.012",
language = "English (US)",
volume = "52",
pages = "370--377",
journal = "Journal of the American Academy of Child and Adolescent Psychiatry",
issn = "0890-8567",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - The bi-directional relationship between parent-child conflict and treatment outcome in treatment-resistant adolescent depression

AU - Rengasamy, Manivel

AU - Mansoor, Brandon M.

AU - Hilton, Robert

AU - Porta, Giovanna

AU - He, Jiayan

AU - Emslie, Graham J.

AU - Mayes, Taryn

AU - Clarke, Gregory N.

AU - Wagner, Karen

AU - Keller, Martin B.

AU - Ryan, Neal D.

AU - Birmaher, Boris

AU - Shamseddeen, Wael

AU - Asarnow, Joan Rosenbaum

AU - Brent, David A.

PY - 2013/4

Y1 - 2013/4

N2 - Objective: To examine the bidirectional relationship between parent-child discord and treatment outcome for adolescent treatment-resistant depression. Method: Depressed youth who had not responded to an adequate course of a selective serotonin reuptake inhibitor (SSRI) were randomized to either a switch to another SSRI or venlafaxine, with or without the addition of cognitive behavior therapy (CBT) in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) study. The Conflict Behavior Questionnaire was used to assess adolescent (CBQ-A) and parent-reported (CBQ-P) parent-child discord. The impact of remission on parent-child conflict, and the differential impact of medication and CBT on the CBQ-A and CBQ-P, were assessed using generalized linear models. Results: Although there were no differential treatment effects on parent or adolescent-report of conflict, remission was associated with improvement in the CBQ-P. In general, intake family conflict did not predict remission, except in the sub-group of participants whose parents reported clinically significant parent-child conflict at intake, for whom high levels of parent-reported conflict predicted a lower likelihood of remission. Conflict also did not moderate treatment response. Conclusions: Remission of depression may be sufficient to reduce parent-reported parent-child conflict. However, higher parent-reported conflict, in the clinically significant range, predicts a lower likelihood of remission from depression. Clinical trial registration information- Treatment of SSRI-Resistant Depression in Adolescents (TORDIA); http://clinicaltrials.gov/; NCT00018902.

AB - Objective: To examine the bidirectional relationship between parent-child discord and treatment outcome for adolescent treatment-resistant depression. Method: Depressed youth who had not responded to an adequate course of a selective serotonin reuptake inhibitor (SSRI) were randomized to either a switch to another SSRI or venlafaxine, with or without the addition of cognitive behavior therapy (CBT) in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) study. The Conflict Behavior Questionnaire was used to assess adolescent (CBQ-A) and parent-reported (CBQ-P) parent-child discord. The impact of remission on parent-child conflict, and the differential impact of medication and CBT on the CBQ-A and CBQ-P, were assessed using generalized linear models. Results: Although there were no differential treatment effects on parent or adolescent-report of conflict, remission was associated with improvement in the CBQ-P. In general, intake family conflict did not predict remission, except in the sub-group of participants whose parents reported clinically significant parent-child conflict at intake, for whom high levels of parent-reported conflict predicted a lower likelihood of remission. Conflict also did not moderate treatment response. Conclusions: Remission of depression may be sufficient to reduce parent-reported parent-child conflict. However, higher parent-reported conflict, in the clinically significant range, predicts a lower likelihood of remission from depression. Clinical trial registration information- Treatment of SSRI-Resistant Depression in Adolescents (TORDIA); http://clinicaltrials.gov/; NCT00018902.

KW - Cognitive behavior therapy (CBT)

KW - Depression

KW - Parent-child conflict

KW - Selective serotonin reuptake inhibitor (SSRI)

KW - Venlafaxine

UR - http://www.scopus.com/inward/record.url?scp=84876815115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876815115&partnerID=8YFLogxK

U2 - 10.1016/j.jaac.2013.01.012

DO - 10.1016/j.jaac.2013.01.012

M3 - Article

VL - 52

SP - 370

EP - 377

JO - Journal of the American Academy of Child and Adolescent Psychiatry

JF - Journal of the American Academy of Child and Adolescent Psychiatry

SN - 0890-8567

IS - 4

ER -